BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹935.05
- Market cap
- ₹14,894 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 56.6×Sector 49.0×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Debt & Borrowing
Jubilant Pharmova's postal ballot approved a special resolution for issuing Non-Convertible Debentures on a private placement basis, with 99.39% votes in favour. The NCD issue approval is a debt-raising step, so it is classified as Debt & Credit.
Jubilant Pharmova Earnings Call Transcript: Key Takeaways
Revenue rose 21% YoY to ₹2,370 Cr, but PAT was only ₹31 Cr as margins fell on Montreal losses (>₹80 Cr in Q2). Management guides H2 mid-teen margins and deferred FY28 guidance.
Jubilant Pharmova Employee Stock Options
Jubilant Pharmova approved a grant of 1,907 RSUs to eligible employees under its 2018 ESOP plan. No monetary event value is disclosed.
- Execution
- Vesting over 3 years from the date of grant; exercisable within 1 year of vesting
Jubilant Pharmova Results Update
Q2 revenue rose 21% to Rs 2,370 Cr, but EBITDA fell 27% and PAT dropped to Rs 31 Cr. SPECT supply gaps and remediation costs compressed margins.
Jubilant Pharmova Q2 FY27 Results: Net Profit ₹31 Cr, Down 74.1% YoY
Jubilant Pharmova Ltd reported revenue from operations of ₹2,370 Cr (+20.5% YoY) and net profit of ₹31 Cr (-74.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31 Cr · -74.1% YoY
Jubilant Pharmova Business Update
Jubilant Pharmova's subsidiary Jubilant Therapeutics will present preliminary Phase 1 clinical data for JBI-802 at the 68th ASH meeting. A company event on December 14, 2026 will discuss the data.
Other annual general meeting announcements
All →Carnation Industries Annual General Meeting
Carnation Industries will hold its FY 2023-24 AGM on December 16, 2026, delayed by CIRP. Agenda includes a name change to Chateau Indage Beverages and shifting the registered office to Delhi.
Priority Jewels Annual General Meeting
Priority Jewels will hold its 19th AGM via video conferencing on December 14, 2026. Agenda includes ESOP ratifications, a director reappointment and charges for document service.
Avalon Technologies Annual General Meeting
Avalon Technologies held its EGM on November 21, 2026, transacting an articles alteration and a preferential warrant issue. Voting results and scrutinizer report to follow.
Wealth First Portfolio Managers Annual General Meeting
Wealth First held its EGM on November 21, 2026, by video conference. Members considered a non-cash preferential share issue and a related-party transaction.
Sakuma Exports Annual General Meeting
Sakuma Exports Limited's EGM on 21 November 2026 lapsed for want of quorum and was adjourned. The meeting is rescheduled to 28 November 2026 by video conference.
Suprajit Engineering Annual General Meeting
Suprajit Engineering seeks shareholder approval via postal ballot to appoint Dr. Steffen Berns as Independent Director. E-voting closes December 22, 2026.